Sakiko Fukuda-Parr

Conversations on the Frontline: The Future Politics and Geography of Vaccine Supply

|2025-09-04T14:47:26-04:00December 14th, 2021

Achal Prabhala, coordinator for the AcesssIBSA project which campaigns for access to medicines and vaccines, discusses the politics and shifting geographies of COVID-19 vaccine access.

Human Rights and Global Responses to the Pandemic in the Age of Hyper-globalization

|2025-09-04T14:47:44-04:00December 13th, 2021

The age of hyper-globalization requires global institutions to contain pandemics worldwide in a way that builds on international solidarity and human rights norms, writes Sakiko Fukuda-Parr, co-editor of Pandemic Discourses.

Pandemic Treaty Needs to Start with Rethinking the Paradigm of Global Health Security

|2025-09-04T14:49:43-04:00August 4th, 2021

Discussions about a new Pandemic Treaty underscore the imperative of rethinking the paradigm of global health security, writes Sakiko Fukuda-Parr, Paulo Buss, and Alicia Ely Yamin.

Conversations on the Frontline: Thinking Long Term and Building Local Capacity

|2025-09-04T14:52:07-04:00May 14th, 2021

Burcu Kilic, research director for Public Citizen's Access to Medicines Program, discusses the complex web of COVID-19 intellectual property protection, and the new possibilities of emerging manufacturing capacity in the Global South.

Conversations on the Frontline: From the Politics of Solidarity to the Politics of Fear

|2025-09-04T14:53:52-04:00April 27th, 2021

In the second interview as part of our new series, "Politics of Vaccine Equity: Conversations on the Frontline," public health consultant and lawyer, Rohit Malpani, discusses how since the HIV/AIDS pandemic there has been from a shift from politics to geopolitics, the new role that emerging economies play in the global landscape of COVID-19 vaccine access, and the importance of technology platforms.

Conversations on the Frontline: Pharmaceutical Companies – What is the Way Forward?

|2025-09-04T14:54:09-04:00April 23rd, 2021

In the first interview as part of our new series, "Politics of Vaccine Equity: Conversations on the Frontline," public health expert and senior policy advisor to the People's Vaccine Alliance, Mohga Kamal-Yanni, discusses how countries are at the whim of Big Pharma for supplying COVID-19 vaccines.

Go to Top